Drug Companies Draw $22M Fine From KFTC

Law360, New York (November 1, 2007, 12:00 AM EDT) -- South Korea’s antitrust regulator has slapped 10 pharmaceutical companies with a $22.2 million fine after finding they provided kickbacks to hospitals and wholesalers.

The Korean Fair Trade Commission said Thursday that the companies, which include Dong-A-Pharmaceutical, Hanmi Pharmaceutical and Yuhan Corp., offered a series of incentives to physicians and hospitals if they made use of their drugs.

The companies typically gave out free dinners, rounds of golf and overseas trips as incentives. In some instances, they offered physicians and hospitals money in the form of “post-market...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.